A pilot study exploring the role of glucocorticoid receptor variants in primary biliary cirrhosis and primary sclerosing cholangitis

Netherlands Journal of Medicine

Volumn 62, Issue 9, 2004, Pages 326-331

  ter Borg, P C J ^a   Hagendorf, A ^a   van Buuren, H R ^a   Koper, J W ^a   Lamberts, S W J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR BETA; MESSENGER RNA;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; ENZYME ACTIVITY; FATIGUE; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN VARIANT;

ADULT; AGED; CASE-CONTROL STUDIES; CHOLANGITIS, SCLEROSING; FATIGUE; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; PILOT PROJECTS; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER;

EID: 6444237188     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Hoogstraten HJF van, Hansen BE, Buuren HR van, Kate FJW ten, Berge Henegouwen GP van, et al. Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis. J Hepatol 1999;31:256-62.
2. Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996;38(4):610-5.
3. Huet PM, Deslauriers J, Tran A, Faucher C, Charbonneau J. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol 2000;95(3):760-7.
4. Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989;10(4):430-6.
5. Wiesner RH, LaRusso NF, Ludwig J, Dickson ER. Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 1985;88(1 Pt1)108-14.
6. Cauch-Dudek K, Abbey S, Stewart DE, Heathcote EJ. Fatigue in primary biliary cirrhosis. Gut 1998;43(5):705-10.
7. Bergasa NV, Mehlman JK, Jones EA. Pruritus and fatigue in primary biliary cirrhosis. Baillieres Best Pract Res Clin Gastroenterol 2000;14(4):643-55.
8. Gluud C, Christensen E. Ursodeoxycholic acid for primary biliary cirrhosis. Cochrane Database Syst Rev 2002(1):CD000551.
9. Kavelaars A, Kuis W, Knook L, Sinnema G, Heijnen CJ. Disturbed neuro-endocrine-immune interactions in chronic fatigue syndrome. J Clin Endocrinol Metab 2000;85(2):692-6.
10. Beato M, Truss M, Chavez S. Control of transcription by steroid hormones. Ann NY Acad Sci 1996;784:93-123.
11. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985;318(6047):635-41.
12. Krett NL, Pillay S, Moalli PA, Greipp PR, Rosen ST. A variant glucocorticoid receptor messenger RNA is expressed in multiple myeloma patients. Cancer Res 1995;55(13):2727-9.
13. Lange P de, Segeren CM, Koper JW, Wiemer E, Sonneveld P, Brinkmann AO, et al. Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells. Cancer Res 2001;61(10):3937-41.
14. Honda M, Orii F, Ayabe T, Imai S, Ashida T, Obara T, et al. Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology 2000;118(5):859-66.
15. Christodoulopoulos P, Leung DY, Elliott MW, Hogg JC, Muro S, Toda M, et al. Increased number of glucocorticoid receptor-beta-expressing cells in the airways in fatal asthma [In Process Citation]. J Allergy Clin Immunol 2000;106(3):479-84.
16. Hamid QA, Wenzel SE, Hauk PJ, Tsicopoulos A, Wallaert B, Lafitte JJ, et al. Increased glucocorticoid receptor beta in airways cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 1999;159(5 Pt1):1600-4.
17. Sousa AR, Lane SJ, Cidlowski JA, Staynov DZ, Lee TH. Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform. J Allergy Clin Immunol 2000;105(5):943-50.
18. Oakley RH, Webster JC, Sar M, Parker CR Jr, Cidlowski JA. Expression and subcellular distribution of the beta-isoform of the human glucocorticoid receptor. Endocrinology 1997;138(11):5028-38.
19. Pujols L, Mullol J, Roca-Ferrer J, Torrego A, Xaubet A, Cidlowski JA, et al. Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues. Am J Physiol Cell Physiol 2002;283(4):C1324-31.
20. Leung DYM, Hamid Q, Vottero A, Szefler SJ, Surs W, Minshall E, et al. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J Exp Med 1997;186(9):1567-74.
21. Orii F, Ashida T, Nomura M, Maemoto A, Fujiki T, Ayabe T, et al. Quantitative as for human glucocorticoid receptor alpha/beta mRNA in IBD. Biochem Biophys Res Commun 2002;296(5):1286-94.
22. Webster JC, Oakley RH, Jewell CM, Cidlowski JA. Proinflammatory cytokines regulate human glucocorticoid recepor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci U S A 2001;98(12):6865-70.
23. Vottero A, Chrousos GP. Glucocorticoid Receptor beta: View I. Trends Endocrinol Metab 1999;10(8):333-8.
24. Harada K, Water J van de, Leung PS, Coppel RL, Ansari A, Nakanuma Y, et al. In situ nucleic acid hybridization of cytokines primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 1997;25(4):791-6.
25. Yamashiki M, Kosaka Y, Nishimura A, Watanabe S, Nomoto M, Ichida F. Analysis of serum cytokine levels in primary biliary cirrhosis patients and healthy adults. J Clin Lab Anal 1998;12(2):77-82.
26. Lohr HF, Schlaak JF, Gerken G, Fleisher B, Dienes HP, Meyer zum Buschenfelde KH. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994;14(3):161-6.
27. Miller LC, Kaplan MM. Serum interleukin-2 and tumor necrosis factor-alpha in primary biliary cirrhosis: decrease by colchicine and relationship to HLA-DR4. Am J Gastroenterol 1992;87(4):465-70.
28. Leuschner M, Maier KP, Schlichting J, Strahl S, Herrmann G, Dahm HH, et al. Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial. Gastroenterology 1999;117(4):918-25.
29. Hoogstraten HJ van, Vleggaar FP, Boland GJ, Steenbergen W van, Griffioen P, Hop WC, et al. Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized doulble-blind pilot study. Belgian-Dutch PSC Study Group [see comments]. Am J Gastroenterol 2000;95(8):2015-22.
30. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994;18(Suppl 1):S79-83.
31. Prince MI, James OF, Holland NP, Jones DE. Validation of a fatigue impact score in primary biliary cirrhosis: towarch a standard for clinical and trial use. J Hepatol 2000;32(3):368-73.
32. Liu Y, Song L, Li B. The expression of glucocorticoid receptor beta messenger RNA in peripheral white blood cells of hormone-resistant nephrotic syndrome patients. Zhonghua Nei Ke Za Zhi 2001;40(11):725-8.
33. Shahidi H, Vottero A, Stratakis CA, Taymans SE, Karl M, Longui CA, et al. Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem Biophys Res Commun 1999;254(3):559-65.
34. Hamilos DL, Leung DY, Muro S, Kahn AM, Hamilos SS, Thawley SE, et al. GRbeta expression in nasal polyp inflammatory cells and its relationship to the anti-inflammatory effects of intranasal fluticasone. J Allergy Clin Immunol 2001;108(1):59-68.
35. Pujols L, Mullo J, Benitez P, Torrego A, Xaubet A, Haro J de, et al. Expression of the glucocorticoid receptor alpha and beta isoforms in human nasal mucosa and polyp epithelial cells. Respir Med 2003;97(1):90-6.
36. Derijk RH, Schaaf MJ, Turner G, Datson NA, Vreugdenhil E, Cidlowski J, et al. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J Rheumatol 2001;28(11):2383-8.
37. Lange P de, Koper JW, Brinkmann AO, Jong FH de, Lamberts SW. Natural variants of the beta isoform of the human glucocorticoid receptor do not alter sensitivity to glucocorticoids. Mol Cell Endocrinol 1999;153(1-2):163-8.
38. Hecht K, Carlstedt-Duke J, Stierna P, Gustafsson J, Bronnegard M, Wikstrom AC. Evidence that the beta-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor. J Biol Chem 1997;272(42):26659-64.
39. Carlstedt-Duke J. Glucocorticoid Receptor beta: View II. Trends Endocrinol Metab 1999;10(8):339-42.
40. Tanaka H, Akama H, Ichikawa Y, Makino I, Homma M. Glucocorticoid receptor in patients with lupus nephritis: relationship between receptor levels in mononuclear leukocytes and effect of glucocorticoid therapy. J Rheumatol 1992;19(6):878-83.
41. Schlaghecke R, Kornely E, Wollenhaupt J, Specker C. Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum 1992;35(7):740-4.
42. Huisman AM, Everdingen AA van, Wenting MJ, Siewertsz Van Reesema DR, Lafeber FP, Jacobs JW, et al. Glucocorticoid receptor downregulation in early diagnosed rheumatoid arthritis. Ann NY Acad Sci 2002;966:64-7.